1. Home
  2. TXMD vs WAL Comparison

TXMD vs WAL Comparison

Compare TXMD & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.00

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$72.25

Market Cap

9.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
WAL
Founded
2008
1994
Country
United States
United States
Employees
N/A
3524
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
9.6B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
TXMD
WAL
Price
$2.00
$72.25
Analyst Decision
Buy
Analyst Count
0
16
Target Price
N/A
$96.73
AVG Volume (30 Days)
20.2K
1.6M
Earning Date
03-30-2026
04-20-2026
Dividend Yield
N/A
2.37%
EPS Growth
73.68
N/A
EPS
N/A
N/A
Revenue
$1,761,000.00
N/A
Revenue This Year
$427.09
$20.25
Revenue Next Year
N/A
$8.09
P/E Ratio
N/A
$10.88
Revenue Growth
35.25
N/A
52 Week Low
$0.84
$57.05
52 Week High
$2.95
$97.23

Technical Indicators

Market Signals
Indicator
TXMD
WAL
Relative Strength Index (RSI) 34.16 46.34
Support Level $1.05 $69.49
Resistance Level $2.05 $81.14
Average True Range (ATR) 0.14 1.94
MACD -0.03 0.99
Stochastic Oscillator 22.00 96.79

Price Performance

Historical Comparison
TXMD
WAL

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: